Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log
- PMID: 3581095
Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log
Abstract
Between August 1984 and November 1985, data concerning 44,156 newly diagnosed cancer patients were entered in the Community Clinical Oncology Program Physician's Patient Log. Forty percent (17,773 patients) had a National Cancer Institute-approved protocol available for site and stage of disease. Fifty-six percent of patients with a protocol available were clinically eligible and 19% were entered on protocol. Thus, one-third of clinically eligible patients were entered in the study. Age was a major factor influencing eligibility and entry on study. Eighty percent of patients less than 25 years of age with a protocol available were clinically eligible for clinical trials participation, and 58% were placed on protocol. Patients greater than or equal to 65 years of age with a protocol available were less likely to be clinically eligible (48%) or placed on study (14%). A physician's preference for an alternate treatment and patient refusal for protocol treatment were also important reasons that clinically eligible patients were not registered on protocol. Selection for clinical trials participation affects the characteristics of patients under study and may have an impact on the ability to generalize the results of clinical trials.
Similar articles
-
An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.Gynecol Oncol. 2004 Aug;94(2):368-74. doi: 10.1016/j.ygyno.2004.05.033. Gynecol Oncol. 2004. PMID: 15297174
-
Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.Cancer. 2002 Sep 1;95(5):989-96. doi: 10.1002/cncr.10792. Cancer. 2002. PMID: 12209681
-
Clinical trial accrual among new cancer patients at a community-based cancer center.Cancer. 2006 Jan 15;106(2):426-33. doi: 10.1002/cncr.21597. Cancer. 2006. PMID: 16353206
-
Participation of adolescents with cancer in clinical trials.Cancer Treat Rev. 2007 Nov;33(7):603-8. doi: 10.1016/j.ctrv.2006.11.005. Epub 2007 Jan 23. Cancer Treat Rev. 2007. PMID: 17250970 Review.
-
Why patients don't take part in cancer clinical trials: an overview of the literature.Eur J Cancer Care (Engl). 2003 Jun;12(2):114-22. doi: 10.1046/j.1365-2354.2003.00396.x. Eur J Cancer Care (Engl). 2003. PMID: 12787008 Review.
Cited by
-
Are racial and ethnic minorities less willing to participate in health research?PLoS Med. 2006 Feb;3(2):e19. doi: 10.1371/journal.pmed.0030019. Epub 2005 Dec 6. PLoS Med. 2006. PMID: 16318411 Free PMC article. Review.
-
Sick population--treated population: the need for a better definition. The VALIDATA Group.Eur J Clin Pharmacol. 1991;41(4):267-71. doi: 10.1007/BF00314951. Eur J Clin Pharmacol. 1991. PMID: 1687120
-
The aged patient with lung cancer. Management recommendations.Drugs Aging. 1994 Jan;4(1):34-46. doi: 10.2165/00002512-199404010-00004. Drugs Aging. 1994. PMID: 8130381 Review.
-
Patient income level and cancer clinical trial participation.J Clin Oncol. 2013 Feb 10;31(5):536-42. doi: 10.1200/JCO.2012.45.4553. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295802 Free PMC article.
-
Recruitment of Ischemic Stroke Patients in Clinical trials in General Practice and Implications for Generalizability of Results.J Vasc Interv Neurol. 2012 Jun;5(1):27-32. J Vasc Interv Neurol. 2012. PMID: 22737263 Free PMC article.
MeSH terms
LinkOut - more resources
Medical